Targeting p38 MAPK: A potential bridge between ER stress and age-related bone loss.
Abstract
The endoplasmic reticulum (ER) is crucial in the development of numerous age-related bone disorders. Notably, ER stress can precipitate bone loss by orchestrating inflammatory responses, apoptosis, and autophagy through the activation of the p38 MAPK pathway. Age-related bone loss diseases pose a significant burden on society and healthcare as the global population ages. This review provides a comprehensive analysis of recent research advancements, delving into the critical role of ER stress-activated p38 MAPK in inflammation, apoptosis, and autophagy, as well as its impact on bone formation and bone resorption. This review elucidates the molecular mechanisms underlying the involvement of ER stress-activated p38 MAPK in osteoporosis, rheumatoid arthritis, periodontitis, and osteoarthritis and discusses the therapeutic potential of targeting p38 MAPK. Furthermore, this review provides a scientific foundation for new therapeutic strategies by highlighting prospective research directions.
The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.
Research summary
The paper discusses the role of ER stress and the p38 MAPK pathway in age-related bone loss, which is a significant aspect of aging and its associated disorders. While it provides a solid review of the mechanisms involved and potential therapeutic strategies, it primarily focuses on treating symptoms rather than addressing the root causes of aging. Therefore, while it contributes to the understanding of age-related diseases, its impact is limited to incremental advances in the field.
Author of this paper? Send a correction.